"Psilocybin Microdosing Reduces Stress-Induced Anhedonia"
A study from the University of Southern Denmark suggests that microdosing psilocybin, the active component in psychedelic mushrooms, may reduce stress-induced anhedonia and compulsive behaviors in rats without inducing significant anxiety or schizophrenic-like symptoms. The study found that rats receiving microdoses maintained a steady preference for sucrose, indicating that they did not lose the ability to feel pleasure, a common symptom in certain mental health disorders like depression. However, the study was conducted on rats, and further research is needed to understand the potential therapeutic benefits and long-term effects of psilocybin microdosing in humans.